Bank Pictet & Cie (Asia)’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $3.55M | Buy |
6,421
+260
| +4% | +$149K | 0.23% | 25 |
|
|
2024
Q1 | $3.58M | Buy |
6,161
+869
| +16% | +$488K | 0.28% | 21 |
|
|
2023
Q4 | $2.81M | Sell |
5,292
-630
| -11% | -$305K | 0.71% | 23 |
|
|
2023
Q3 | $3M | Buy |
5,922
+534
| +10% | +$285K | 0.89% | 21 |
|
|
2023
Q2 | $2.81M | Sell |
5,388
-111
| -2% | -$59.9K | 0.83% | 24 |
|
|
2023
Q1 | $3.17M | Sell |
5,499
-330
| -6% | -$186K | 1.07% | 18 |
|
|
2022
Q4 | $3.21M | Sell |
5,829
-37
| -0.6% | -$19.6K | 1.15% | 18 |
|
|
2022
Q3 | $2.98M | Sell |
5,866
-963
| -14% | -$539K | 1.17% | 19 |
|
|
2022
Q2 | $3.71M | Sell |
6,829
-535
| -7% | -$294K | 1.26% | 17 |
|
|
2022
Q1 | $4.35M | Buy |
7,364
+55
| +0.8% | +$31.6K | 1.18% | 17 |
|
|
2021
Q4 | $4.88M | Buy |
7,309
+1,156
| +19% | +$722K | 1.15% | 16 |
|
|
2021
Q3 | $3.52M | Sell |
6,153
-689
| -10% | -$378K | 0.98% | 17 |
|
|
2021
Q2 | $3.45M | Buy |
6,842
+267
| +4% | +$126K | 0.97% | 17 |
|
|
2021
Q1 | $3M | Buy |
6,575
+161
| +3% | +$76.8K | 0.93% | 16 |
|
|
2020
Q4 | $2.99M | Buy |
6,414
+47
| +0.7% | +$22K | 0.93% | 17 |
|
|
2020
Q3 | $2.81M | Sell |
6,367
-430
| -6% | -$178K | 1.08% | 14 |
|
|
2020
Q2 | $2.46M | Sell |
6,797
-1,488
| -18% | -$499K | 1.06% | 15 |
|
|
2020
Q1 | $2.35M | Buy |
8,285
+401
| +5% | +$126K | 1.13% | 16 |
|
|
2019
Q4 | $2.56M | Buy |
7,884
+565
| +8% | +$171K | 1.1% | 15 |
|
|
2019
Q3 | $2.13M | Buy |
7,319
+30
| +0.4% | +$8.59K | 0.96% | 20 |
|
|
2019
Q2 | $2.14M | Buy |
7,289
+880
| +14% | +$242K | 0.98% | 19 |
|
|
2019
Q1 | $1.75M | Buy |
6,409
+380
| +6% | +$94.6K | 0.83% | 20 |
|
|
2018
Q4 | $1.35M | Sell |
6,029
-1,967
| -25% | -$462K | 0.73% | 21 |
|
|
2018
Q3 | $1.95M | Buy |
7,996
+75
| +0.9% | +$17.3K | 0.9% | 18 |
|
|
2018
Q2 | $1.64M | Sell |
7,921
-10,572
| -57% | -$2.24M | 0.75% | 21 |
|
|
2018
Q1 | $3.82M | Sell |
18,493
-4,383
| -19% | -$920K | 1.81% | 15 |
|
|
2017
Q4 | $4.34M | Sell |
22,876
-3,080
| -12% | -$590K | 1.88% | 14 |
|
|
2017
Q3 | $4.91M | Sell |
25,956
-527
| -2% | -$95.4K | 2.32% | 14 |
|
|
2017
Q2 | $4.62M | Sell |
26,483
-7,344
| -22% | -$1.23M | 2.19% | 15 |
|
|
2017
Q1 | $5.2M | Buy |
33,827
+3,099
| +10% | +$474K | 2.35% | 15 |
|
|
2016
Q4 | $4.34M | Buy |
30,728
+190
| +0.6% | +$28K | 2.21% | 19 |
|
|
2016
Q3 | $4.86M | Buy |
30,538
+1,125
| +4% | +$173K | 2.81% | 17 |
|
|
2016
Q2 | $4.35M | Sell |
29,413
-8,554
| -23% | -$1.26M | 2.78% | 15 |
|
|
2016
Q1 | $5.38M | Sell |
37,967
-6,475
| -15% | -$868K | 3.18% | 10 |
|
|
2015
Q4 | $6.3M | Sell |
44,442
-2,200
| -5% | -$293K | 3.65% | 10 |
|
|
2015
Q3 | $5.7M | Buy |
+46,642
| New | +$6.08M | 4.22% | 9 |
|
|
2015
Q2 | – | Sell |
-38,480
| Closed | -$5.17M | – | 82 |
|
|
2015
Q1 | $5.17M | Sell |
38,480
-3,610
| -9% | -$465K | 3.8% | 7 |
|
|
2014
Q4 | $5.27M | Sell |
42,090
-3,210
| -7% | -$390K | 4.08% | 8 |
|
|
2014
Q3 | $5.51M | Buy |
45,300
+40,750
| +896% | +$4.95M | 4.05% | 10 |
|
|
2014
Q2 | $537K | Buy |
+4,550
| New | +$535K | 0.67% | 38 |
|
Other funds holding TMO
Bank Pictet & Cie (Asia)'s TMO Position: Q2 2024 in Review
Bank Pictet & Cie (Asia) increased its Thermo Fisher Scientific (TMO) stake by 4.2% in Q2 2024, buying an estimated $149K and bringing the position to 6,421 shares worth $3.55M. The position accounts for 0.23% of the portfolio, ranked #25.
Bank Pictet & Cie (Asia) first reported a position in TMO in Q2 2014 and has held it in 40 quarters since. The position peaked at $6.3M in Q4 2015. 2,544 funds tracked by Wall St. Rank hold TMO as of Q2 2024.
- Bank Pictet & Cie (Asia) held 6,421 shares of Thermo Fisher Scientific worth $3.55M as of Q2 2024.
- Bank Pictet & Cie (Asia) bought 260 Thermo Fisher Scientific shares in Q2 2024, an estimated $149K.
- Thermo Fisher Scientific made up 0.23% of Bank Pictet & Cie (Asia)'s portfolio in Q2 2024, its #25 holding.
- Bank Pictet & Cie (Asia) first reported a position in Thermo Fisher Scientific in Q2 2014 and has held it in 40 quarters since.
- Bank Pictet & Cie (Asia)'s Thermo Fisher Scientific position peaked at $6.3M in Q4 2015.
- 2,544 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2024.
Based on Bank Pictet & Cie (Asia)'s 13F filing for Q2 2024, filed 16 Jul 2024.